Company profile
Ticker
AMGN
Exchange
Website
CEO
Mr. Robert A. Bradway
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
AMGEN
SEC CIK
Corporate docs
Subsidiaries
Amgen (Europe) GmbH • Amgen Canada Inc. • Amgen Fremont Inc. • Amgen Global Finance B.V. • Amgen Global Technology Unlimited Company • Amgen GmbH • Amgen Ilaç Ticaret Limited • Amgen International Holdings Inc. • Amgen K.K. • Amgen K-A, Inc. ...
IRS number
953540776
AMGN stock data
Analyst ratings and price targets
Latest filings (excl ownership)
10-K
2024 FY
Annual report
14 Feb 25
8-K
Amgen Reports Fourth Quarter and Full Year 2024 Financial Results
4 Feb 25
10-Q
2024 Q3
Quarterly report
30 Oct 24
8-K
Amgen Reports Third Quarter 2024 Financial Results
30 Oct 24
10-Q
2024 Q2
Quarterly report
6 Aug 24
8-K
Amgen Reports Second Quarter 2024 Financial Results
6 Aug 24
S-8
Registration of securities for employees
12 Jun 24
8-K
Departure of Directors or Certain Officers
3 Jun 24
DEFA14A
Additional proxy soliciting materials
10 May 24
DEFA14A
Additional proxy soliciting materials
3 May 24
Transcripts
AMGN
Earnings call transcript
2024 Q4
4 Feb 25
AMGN
Earnings call transcript
2024 Q3
30 Oct 24
AMGN
Earnings call transcript
2024 Q2
6 Aug 24
AMGN
Earnings call transcript
2024 Q1
2 May 24
AMGN
Earnings call transcript
2023 Q4
6 Feb 24
AMGN
Earnings call transcript
2023 Q3
31 Oct 23
AMGN
Earnings call transcript
2023 Q2
3 Aug 23
AMGN
Earnings call transcript
2023 Q2
3 Aug 23
AMGN
Earnings call transcript
2023 Q1
27 Apr 23
AMGN
Earnings call transcript
2022 Q4
31 Jan 23
Latest ownership filings
144
Notice of proposed sale of securities
18 Feb 25
4
Murdo Gordon
13 Feb 25
144
Notice of proposed sale of securities
11 Feb 25
4
Jonathan P Graham
10 Feb 25
144
Notice of proposed sale of securities
7 Feb 25
4
Nancy A. Grygiel
6 Feb 25
144
Notice of proposed sale of securities
5 Feb 25
4
Jonathan P Graham
6 Dec 24
4
Robert A Bradway
3 Dec 24
4
Rachna Khosla
6 Nov 24
Financial summary
Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Institutional ownership, Q3 2024
75.7% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 2787 |
Opened positions | 171 |
Closed positions | 142 |
Increased positions | 1077 |
Reduced positions | 1118 |
13F shares | Current |
---|---|
Total value | 124.85 tn |
Total shares | 406.98 mm |
Total puts | 7.18 mm |
Total calls | 7.49 mm |
Total put/call ratio | 1.0 |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 52.38 mm | $16.88 tn |
BlackRock | 46.25 mm | $14.90 tn |
STT State Street | 29.32 mm | $9.45 tn |
MS Morgan Stanley | 14.69 mm | $4.73 tn |
Primecap Management | 14.26 mm | $4.59 tn |
Geode Capital Management | 12.12 mm | $3.89 tn |
Charles Schwab Investment Management | 10.53 mm | $3.39 tn |
Capital International Investors | 8.72 mm | $2.81 tn |
WFC Wells Fargo & Company | 7.49 mm | $2.41 tn |
NTRS Northern Trust | 5.56 mm | $1.79 tn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
11 Feb 25 | Gordon Murdo | Common Stock | Sell | Dispose S | No | No | 294.7947 | 8,771 | 2.59 mm | 44,186 |
7 Feb 25 | Jonathan P Graham | Common Stock | Sell | Dispose S | No | No | 293.1173 | 25,045 | 7.34 mm | 28,987 |
7 Feb 25 | Jonathan P Graham | Common Stock | Option exercise | Acquire M | No | No | 156.35 | 25,045 | 3.92 mm | 54,032 |
7 Feb 25 | Jonathan P Graham | Nqso Common Stock | Option exercise | Dispose M | No | No | 156.35 | 25,045 | 3.92 mm | 0 |
5 Feb 25 | Nancy A. Grygiel | Common Stock | Sell | Dispose S | No | No | 304.4731 | 1,589 | 483.81 k | 7,210 |
5 Dec 24 | Jonathan P Graham | Common Stock | Gift | Dispose G | No | No | 0 | 6,430 | 0.00 | 28,903 |
2 Dec 24 | Robert A Bradway | Common Stock | Gift | Dispose G | No | No | 0 | 90,000 | 0.00 | 393,855 |
2 Dec 24 | Robert A Bradway | Common Stock | Gift | Acquire G | Yes | No | 0 | 90,000 | 0.00 | 90,000 |
2 Dec 24 | Robert A Bradway | Common Stock | Gift | Dispose G | No | No | 0 | 96,000 | 0.00 | 573,855 |
News
Amgen Unusual Options Activity For February 12
6d ago
10 Health Care Stocks With Whale Alerts In Today's Session
1w ago
Piper Sandler Maintains Overweight on Amgen, Raises Price Target to $329
1w ago
Uber To $80? Here Are 10 Top Analyst Forecasts For Thursday
1w ago
B of A Securities Maintains Underperform on Amgen, Raises Price Target to $275
1w ago
Press releases
GeminiBio Appoints Mike Stella to Board
14h ago
AMGEN TO PRESENT AT CITI'S 2025 VIRTUAL ONCOLOGY LEADERSHIP SUMMIT
4d ago
AMGEN TO PRESENT AT THE 35th ANNUAL OPPENHEIMER HEALTHCARE LIFE SCIENCES CONFERENCE
1w ago
AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS
2w ago
AMGEN ANNOUNCES WEBCAST OF 2024 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS
2w ago